To identify ABC transporters whose expression is associated with differential patient outcome in EWS, we performed an explorative quantitative reverse transcription PCR (RT-qPCR) analysis of 15 ABC transporters that were reported to play a role in drug resistance/tumor aggressiveness (for a review see [24]). Here, ABCG2 is linked to neoplasm.